Lozupone Madia, Castellana Fabio, Sardone Rodolfo, Berardino Giuseppe, Mollica Anita, Zupo Roberta, De Pergola Giovanni, Griseta Chiara, Stallone Roberta, La Montagna Maddalena, Dibello Vittorio, Seripa Davide, Daniele Antonio, Altamura Mario, Solfrizzi Vincenzo, Bellomo Antonello, Panza Francesco
Neurodegenerative Disease Unit, Department of Basic Medicine, Neuroscience, and Sense Organs, University of Bari Aldo Moro, Bari, Italy.
Healthy Aging Phenotypes Research Unit-"Salus in Apulia Study"-National Institute of Gastroenterology "Saverio de Bellis", Research Hospital, Castellana Grotte, Bari, Italy.
J Am Med Dir Assoc. 2023 May;24(5):679-687. doi: 10.1016/j.jamda.2022.12.005. Epub 2022 Dec 31.
Individuals with late-life depression (LLD) may have shorter survival, but there is a lack of findings in population-based settings about health-related outcomes of LLD and its subtypes: early-onset depression (EOD) and late-onset depression (LOD). We aimed to evaluate the risk of all-cause mortality of individuals with LLD and its subtypes in an older population-based cohort. Moreover, we investigated whether inflammatory, cognitive, genetic features and multimorbidity could modify the effect of this association.
Longitudinal population-based study with 8-year follow-up.
We analyzed data on a sample of 1479 participants, all aged >65 years, in the Salus in Apulia Study.
LLD was diagnosed through DSM-IV-TR criteria and LOD and EOD according to the age of onset. Multimorbidity status was defined as the copresence of 2 or more chronic diseases.
The overall prevalence of LLD in this older sample from Southern Italy was 10.2%, subdivided into 3.4% EOD and 6.8% LOD. In multivariable Cox models adjusted for age, gender, education, global cognition, apolipoprotein E ε4 allele, physical frailty, interleukin-6, and multimorbidity, LLD showed a greater risk of all-cause mortality. LOD differed from EOD regarding gender, education, cognitive dysfunctions, and diabetes mellitus. There was a significantly increased risk of all-cause mortality for participants with LOD (hazard ratio:1.99; 95% CI 1.33-2.97) in the time of observation between enrollment date and death date (7.31 ± 2.17 months).
In older age, individuals with LOD but not with EOD had a significantly decreased survival, probably related to increased inflammation, multimorbidity, and cognitive impairments.
患有老年期抑郁症(LLD)的个体可能生存期较短,但在基于人群的研究中,关于LLD及其亚型早发性抑郁症(EOD)和晚发性抑郁症(LOD)的健康相关结局缺乏研究结果。我们旨在评估基于老年人群队列中LLD及其亚型个体的全因死亡风险。此外,我们研究了炎症、认知、遗传特征和多种疾病共存是否会改变这种关联的影响。
进行为期8年随访的基于人群的纵向研究。
我们分析了阿普利亚健康研究中1479名年龄均大于65岁的参与者的数据。
根据《精神疾病诊断与统计手册》第四版修订版(DSM-IV-TR)标准诊断LLD,并根据发病年龄诊断LOD和EOD。多种疾病共存状态定义为同时存在2种或更多种慢性疾病。
在这个来自意大利南部的老年样本中,LLD的总体患病率为10.2%,其中EOD为3.4%,LOD为6.8%。在对年龄、性别、教育程度、整体认知、载脂蛋白E ε4等位基因、身体虚弱、白细胞介素-6和多种疾病共存进行调整的多变量Cox模型中,LLD显示出更高的全因死亡风险。LOD在性别、教育程度、认知功能障碍和糖尿病方面与EOD不同。在入组日期和死亡日期之间的观察期内(7.31±2.17个月),患有LOD的参与者全因死亡风险显著增加(风险比:1.99;95%置信区间1.33 - 2.97)。
在老年人群中,患有LOD而非EOD的个体生存期显著缩短,可能与炎症增加、多种疾病共存和认知障碍有关。